Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial.
BACKGROUND: In the Platelet Inhibition and Patient Outcomes (PLATO) trial, a prespecified subgroup analysis showed a significant interaction between treatment and region (P=0.045), with less effect of ticagrelor in North America than in the rest of the world. METHODS AND RESULTS: Reasons for the int...
| Publicado en: | Circulation Vol. 124; no. 5; pp. 544 - 555 |
|---|---|
| Autores principales: | , , , , , , , , , , , , |
| Formato: | clinical trial research Journal Article |
| Publicado: |
Lippincott Williams & Wilkins
8/2/2011
|
| Acceso en línea: | Ver este registro en EBSCOhost |